AT1R antagonist treatment attenuates the hyperoxia-induced lung fibrosis and decreases the hyperoxia-induced expression of extracellular signal-regulated protein kinase and α-SMA in hyperoxia-exposed newborn rats [22]. This evidence concerns the gene AGTR1 and pulmonary fibrosis.